Universal Time: 15:22  |  Local Time: 15:22 (0h GMT)
Select your timezone:
Reset

Sun Sep 13

00:00 Symposium: Lessons Learned about COVID-19
105.4 Immunogenetics (HLA and ABO)
Lori Jeanne West, Canada
105.6 Global Impact of COVID-19 on Transplantation
Alexandre Loupy, France
105.1 Virology, Epidemiology and Clinical Course
Olivia S. Kates, United States
105.2 Organ Specific Involvement of COVID-19
Aneesha Anand Shetty, United States
105.3 Diagnostics:  PCR, Antigen Detection and Serology 
Robin Patel, United States
105.5 Therapeutics & Vaccines
Michael G. Ison, United States
00:00 Symposium: Transplanting in the Era of COVID-19
110.2 When a Recipient with COVID-19 Can Proceed to Transplant
Paolo Antonio Grossi, Italy
110.1 Donor Screening and the Risk of Virus Transmission
Thomas D. Mone, United States
110.4 Transplantation in the Hot Zone
Jean C. Emond, United States
110.3 Lung Transplantation for COVID-19
Jingyu Chen, People's Republic of China
110.5 Transplantation and Ethical Issues in the COVID Era: Doing the right thing depends on location, resources and disease burden
Peter G. Stock, United States

Mon Sep 14

00:15 - 02:00 State-of-the-Art Session: Expanding the Donor Pool, Pushing the Limits
222.2 Use of DCD organs in heart and lung transplant
Gregory I Snell, Australia
222.1 Use of HCV positive organs into HCV negative recipients
David Goldberg, United States
222.3 Transplant outcomes from older donors > Age 60
Colleen L. Jay, United States
07:30 - 08:15 Oral Abstracts Session: Kidney Transplantation: Underlying diseases and infections
250.1 Cryptococcoma due to Cryptococcus albidus of a transplant kidney in a patient presenting with recurrent urinary tract infection: A clinical and metagenome sequencing study
Ziyan Yan, People's Republic of China
250.4 H1N1: A forgotten and mysterious entity in post renal transplant patients
Sanshriti Chauhan, India
250.3 DEEPGRAFT, a deep learning algorithm to classify kidney transplant diseases from digital whole slide biopsy images
Jesper Kers, Netherlands
250.2 Relationship between circulatory T follicular helper cells and CMV infection in kidney transplant recipients
Patricia Suàrez-Fernández, Spain
08:15 - 10:00 State-of-the-Art Session: Managing Immunosuppression When Things Go Wrong
261.1 Managing IS in recipients with a failing graft
Sangho Lee, Korea
261.3 Managing IS in recipients treated for malignancies
Daniel Seron, Spain
261.2 Managing IS in recipients with complex infections
Peter Chin-Hong, United States
15:15 - 17:00 State-of-the-Art Session: Social Media for Scientists
291.3 Impact of social media on research dissemination
Carla C. Baan, Netherlands
291.1 Introduction and creating networks
Frank JMF Dor, United Kingdom
291.2 Healthcare and patient education
Macey L. Henderson, United States
22:00 - 23:30 Workshop Session: What the ID Doc should know about …
302.4 Rejection in intestinal transplant
Gabriel E. Gondolesi, Argentina
302.1 CLAD
Gregory I Snell, Australia
302.2 Bilomas
Prema Raj Jeyaraj, Singapore
302.3 Delayed allograft function after renal transplant
Roslyn B Mannon, United States

Tue Sep 15

00:15 - 02:00 Workshop Session: Sex in the Time of SARS-CoV-2 – Relevance to transplantation
323.1 Sex, gender, and their impact on COVID 19
Deborah Clegg, United States
323.2 Sex mAtteRS-CoV-2 in Transplantation
Ruth Sapir-Pichhadze, Canada
323.3 Panelists
Bethany J. Foster, Canada
Biff F. Palmer, United States
Amanda Vinson, Canada
07:30 - 08:15 Oral Abstracts Session: Infectious Diseases
353.2 A recent diagnosis of tuberculosis is a risk factor for post-transplant morbidity & mortality after liver transplantation: A propensity score match-based analysis
Pradez Sapkota, India
353.3 Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab
Hyunwook Kwon, Korea
353.4 Gram negative blood stream infection in renal transplant recipients: Risk factors and outcome from a transplant center in Pakistan
Sunil Kumar Dodani, Pakistan
353.5 (P-9.02 in Journal) Impact of non-active hepatitis B on patient survival after renal transplantation
Marcel RG Naik, Germany
15:15 - 17:00 State-of-the-Art Session: How Sex Impacts Post-Transplant Course
392.2 Sex differences in infection risks and vaccine responses
Deepali Kumar, Canada
392.1 Sex differences in cancer risk post-transplant
Anna Buxeda, Spain
392.3 Sex and the heart: Major cardiovascular events in transplantation
Darshana Dadhania, United States
23:30 - 00:15 Oral Abstracts Session: Kidney Transplantation: Novel approaches to monitoring
410.1 (P-11.189 in the Journal) Reactivation of murine polyomavirus replication by renal ischemia-reperfusion injury and immunosuppression
Gang Huang, People's Republic of China
410.3 Analysis of the difference of the monitoring results of TCR high variable area in renal transplant recipients after treatment with different immune induction schemes
Tian Puxun, People's Republic of China
410.4 Novel human kidney cell subsets identified by Mux-Seq
Tara Sigdel, United States

Wed Sep 16

00:15 - 02:00 State-of-the-Art Session: Preventable Infections - An Ounce of Prevention...
420.2 Screening and decolonization of MDROs pre-transplant: Is there a role?
Stephanie Pouch, United States
420.1 Respiratory viruses - Impact on our recipients
Michael G. Ison, United States
420.3 Keeping the fungi out of the transplant ward
Monica Slavin, Australia
00:15 - 02:00 State-of-the-Art Session: Challenges for Solid Organ Tx in the Developing World
421.1 What should be our focus to improve equity and access to transplant "all organs" in middle income countries?
Liliana Bisigniano, Argentina
421.3 Pediatric liver & kidney transplantation in developing countries: deceased vs living donor transplants, challenges, disparities, results and developments. How to increase applicability?
Pranjal Modi, India
421.2 Which diseases are unique in middle income countries, and what should we learn to avoid transmission when a transplant recipient fly abroad?
Camille Nelson Kotton, United States
13:00 - 14:30 Workshop Session: CMV - What's New
477.3 New risks for CMV in solid organ and stem cell transplant recipients
José Maria Aguado, Spain
477.1 New drugs against an old foe
Francisco M Marty, United States
477.2 Immune monitoring
Camille Nelson Kotton, United States
14:30 - 15:15 Oral Abstracts Session: Donation Issues
481.4 Evaluation of the mechanism of action of hepatic hypothermic oxygenated machine perfusion (HOPE) using microdialysis in a clinical setting
Damiano Patrono, Italy
481.1 Consent to organ offers from public health service “increased risk” donors decreases time to transplant and waitlist mortality
Yvonne Kelly, United States
481.2 Executive order on advancing american kidney health: A Markov analysis of long-term costs
Rashikh A Choudhury, United States
481.3 Outcomes of non-liver solid organ transplantation using hepatitis C positive donors to hepatitis C negative recipients: A multicenter experience
Kristen L Ryland, United States
15:15 - 17:00 State-of-the-Art Session: Paediatric Transplantation Around the World
491.1 Paediatric kidney transplantation around the world
Mignon McCulloch, South Africa
491.2 Cost Effective Immunosuppressive Medications Around the World
Katherine Twombley, United States
491.3 Variety of vaccine preventive paediatric infectious diseases around the world
Lara Danziger-Isakov, United States
18:00 - 19:00 Post-Congress Symposium: The Basics I – Expert Approaches
500.2 My approach to CMV in organ transplantation
Raymund Razonable, United States
500.1 My approach to BKV in renal transplantation
Joanna Schaenman, United States
500.3 My approach to HCV in organ transplantation
Nassim Kamar, France
500.4 My approach to HBV in organ transplantation
Wan Cheng Chow, Singapore
18:00 - 19:00 Post-Congress Symposium: The Basics II – Pre-Transplant Problems
505.3 The lung transplant patient with NTM
Shahid Husain, Canada
505.4 Excluding Covid-19 in deceased donors – the role of serology and PCR
Wanessa Trindade Clemente, Brazil
505.1 Preparing the patient for an intestinal transplant – the ID perspective
Fernanda Silveira, United States
18:00 - 19:00 Post-Congress Symposium: Some Specifics I – Testing, Testing
510.4 Next generation sequencing – how will it benefit the transplant recipient
William David Rawlinson, Australia
510.3 Urinalysis and urine cultures in kidney recipient follow-up – right or wrong
Kyong-Ran Peck, Korea
510.2 Meningitis and GI panels – boon or bane to TID?
Siriorn Watcharananan, Thailand
510.1 Treating all that’s + in BAL in lung transplant – right or wrong
Robin Avery, United States
18:00 - 19:00 Post-Congress Symposium: Some Specifics II – Less common, but not less important
515.2 Treating TB post-transplant
Guilherme Santoro Lopes, Brazil
515.4 Cryptococcus – from pre- to post-transplant management
Hsin-Yun Sun, Taiwan
515.1 PCP prophylaxis - the small print
Jay A. Fishman, United States
515.3 Strongyloides – the forgotten worm
Michele Ilene Morris, United States

E-Posters

Poster Session: Infectious Disease
P-9.01 Vaccine-preventable infections among solid organ transplant recipients: a data-linked cohort study, Australia, 2000-2015
Karen Waller, Australia
P-9.03 Aspergillosis complicating severe Influenza and RSV pneumonia in ICU patients: A retrospective cohort study
Hannah H Nam, United States
P-9.05 The level of plasm donor-derived cell-free DNA in kidney transplant patients with severe pneumonia
Liu Feng, People's Republic of China
P-9.07 Acquisition and kinetics of EBV infection amongst pediatric liver transplant recipients in Japan
Masaki Yamada, Japan
P-9.08 New blood borne virus infections among organ transplant recipients: a data-linked cohort study examining transmitted and de novo hepatitis B, C and HIV infections
Karen Waller, Australia
P-9.10 Ten year challenge: How the etiology and resistance patterns of blood stream ınfections in solid organ transplantation recipients have changed?
Cigdem Erol, Turkey
P-9.11 Impact of Cytomegalovirus (CMV) infection in post renal transplant: A single center experience
Rutul Manojkumar Dave, India
P-9.15 BK virus allograft nephropaty in renal transplant recipients
Nasly G Patino-Jaramillo MD, Colombia
P-9.17 Lymphocytopenia and neutrophilia determined fungal infection occurrence and mortality after liver transplantation
Jiang Liu, People's Republic of China
P-9.19 Epidemiology of Nocardia spp infections in heart transplant recipients at a single center
Hannah H Nam, United States
P-9.20 Clinical characteristics and outcome of herpes zoster in solid organ transplant patients: A single center case series
Cemile Tugba Altunel, Turkey
P-9.21 Residual foreign body and frequency of infection after heart transplantation
Michiru Nomoto, Japan
P-9.22 Last two influenza season: Evaluation of solid organ transplant recipients
Hande Arslan, Turkey
P-9.23 Clinical characteristics and long-term outcomes of cryptococcosis in solid organ transplant recipients
Pakpoom Phoompoung, Thailand
P-9.24 Herpes simplex virus type 1 encephalitis in kidney transplant patient: A case report
Nasly G Patino-Jaramillo MD, Colombia
P-9.27 Variation of BKV DNA quantitation in neat and stabilized urine due to target inhomogeneity
Akos Somoskovi, United States

WebApp Sponsor

© 2020 TTS 2020